Pfizer has warned that a drug used to treat syphilis and other bacterial infections in children could run out by the end of June because it has had to prioritize versions made for adults due to a spike in syphilis infections in that population.
https://www.pharmalive.com/wp-content/uploads/2023/05/ReutersPfizer5-30-2023.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-06-13 21:10:392023-06-14 08:39:08Pfizer expects to run out of some antibiotic supply for children soon
